Difficulty: Medium
Average Score: 74%
Practice
Supplementary folinic acid may prevent anemia in folate-deficient persons who use this drug; it is a weak base, and achieves tissue levels similar to those in plasma
Correct answer
D
Rationale
In this case, the correct answer is D) Trimethoprim. The rationale behind this is that trimethoprim is known to inhibit dihydrofolate reductase, an enzyme involved in the folate pathway. By inhibiting this enzyme, trimethoprim interferes with the production of tetrahydrofolic acid, which is essential for DNA synthesis.
Supplementary folinic acid, which is a reduced form of folic acid, can help prevent anemia in individuals who are folate-deficient while using trimethoprim. This is because folinic acid bypasses the enzymatic block caused by trimethoprim, ensuring that the body has an adequate supply of tetrahydrofolic acid for essential cellular processes.
Now, let's discuss why the other options are incorrect:
A) Ciprofloxacin and B) Norfloxacin are fluoroquinolone antibiotics that do not interfere with the folate pathway and are not typically associated with folate deficiency-related anemia.
C) Sulfacetamide is a sulfonamide antibiotic that works by inhibiting bacterial synthesis of folic acid, but it does not have the same mechanism of action as trimethoprim in inhibiting dihydrofolate reductase.
Educational context: Understanding the interactions between drugs and essential pathways in the body is crucial in pharmacology. In this scenario, students learn how different drugs can affect folate metabolism and the potential role of supplementary folinic acid in mitigating adverse effects. This knowledge is vital for healthcare professionals to make informed decisions when managing patients receiving multiple medications.
Supplementary folinic acid, which is a reduced form of folic acid, can help prevent anemia in individuals who are folate-deficient while using trimethoprim. This is because folinic acid bypasses the enzymatic block caused by trimethoprim, ensuring that the body has an adequate supply of tetrahydrofolic acid for essential cellular processes.
Now, let's discuss why the other options are incorrect:
A) Ciprofloxacin and B) Norfloxacin are fluoroquinolone antibiotics that do not interfere with the folate pathway and are not typically associated with folate deficiency-related anemia.
C) Sulfacetamide is a sulfonamide antibiotic that works by inhibiting bacterial synthesis of folic acid, but it does not have the same mechanism of action as trimethoprim in inhibiting dihydrofolate reductase.
Educational context: Understanding the interactions between drugs and essential pathways in the body is crucial in pharmacology. In this scenario, students learn how different drugs can affect folate metabolism and the potential role of supplementary folinic acid in mitigating adverse effects. This knowledge is vital for healthcare professionals to make informed decisions when managing patients receiving multiple medications.